Class Action Lawsuit Against Celsius Holdings
Pomerantz LLP has made headlines by filing a class action lawsuit against Celsius Holdings, Inc. and its officers, aiming to draw attention to the safety risks associated with their Alani Nu energy drink products. The suit, lodged in the Southern District of Florida, highlights concerns regarding the marketing and safety of these drinks, particularly for younger consumers.
Background and Class Period
The legal action targets any individual or entity, excluding the defendants, who purchased Celsius securities from February 21, 2025, to June 3, 2026. The claim seeks redress for damages arising from alleged violations of federal securities laws under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as well as Rule 10b-5.
Who Can Join the Class Action?
Individuals who bought Celsius securities during the defined class period have until November 3, 2026, to request certification as a Lead Plaintiff in the suit. From the Pomerantz website, potential plaintiffs can acquire a copy of the Complaint as well as necessary details about the joining process.
Safety Concerns with Alani Nu
Celsius manufactures, markets, and distributes energy products, including its recent acquisition, Alani Nutrition LLC, well-known for its high-caffeine energy drinks. The acquisition took place on April 1, 2025, for a reported $1.65 billion. Allegations assert that despite Celsius claiming their drinks are healthy, there is significant risk due to the caffeine content—200 milligrams in a single 12-ounce serving. This exceeds the 100-milligram per day guideline advised for teenagers by various health organizations.
Regulatory Warnings and Legal Action
In 2023, Alani Nu faced scrutiny from Canadian authorities prompting a warning against consuming their energy drinks which exceeded the country’s caffeine regulations. This has since brought to light that Celsius is responsible for promoting these drinks to minors, which raises ethical questions and poses health risks to a vulnerable demographic.
Promotional strategies have actively targeted the younger audience, with vibrant packaging and social media campaigns aimed at college students. The Alani Ambassador program, where students endorse the products online, adds to these concerns, given that up to 25% of their audience may fall under the age of 18.
Misleading Claims
The complaint asserts that Celsius made materially misleading statements regarding the product safety and marketing practices related to Alani Nu. Not only did they fail to adequately warn consumers about the potential cardiac risks associated with high caffeine intake, but they also allegedly misrepresented their marketing strategies that targeted underage consumers. According to the allegations, this behavior directly correlated with a heightened risk of health issues, making the company vulnerable to lawsuits and regulatory actions.
Impact of Public Controversy
Notably, the family's wrongful death lawsuit filed in connection with the tragic death of a Texas teenager, attributed to consuming Alani Nu drinks, catalyzed a remarkable decrease in Celsius's stock price. Additionally, the Texas Attorney General has opened an investigation into potential violations of the state's deceptive trade practices laws concerning Celsius’s marketing tactics.
The Road Ahead
Pomerantz LLP aims to hold Celsius accountable for these serious allegations. The firm specializes in corporate and securities litigation, and their history in successfully advocating for the rights of investors drives this current action. In summary, this lawsuit not only seeks compensation for potential damages suffered by investors but also highlights the pressing issue of product safety concerning energy drinks marketed to young consumers.
For additional inquiries or to join the class action, interested parties can reach out to hosts at Pomerantz LLP. The firm remains steadfast in its pledge to fight against corporate malfeasance, advocating for victims who may otherwise not have a voice in the marketplace.
For more information, visit
Pomerantz's official website.